Insulin pump therapy for type 2 diabetes

Current Diabetes Reports

Volumn 3, Issue 5, 2003, Pages 373-377

  Kirk, Susan E ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLICLAZIDE; GLUCOSE; HYDROCORTISONE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN LISPRO; LONG ACTING DRUG; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT; SHORT ACTING DRUG;

CATHETER INFECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; DRUG INDICATION; DRUG USE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; INTERMETHOD COMPARISON; LIFESTYLE; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; REVIEW; SIDE EFFECT; SKIN ALLERGY; WEIGHT GAIN; INFUSION PUMP; INSULIN INFUSION; TREATMENT OUTCOME;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INFUSION PUMPS, IMPLANTABLE; INSULIN INFUSION SYSTEMS; TREATMENT OUTCOME;

EID: 0242271881     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-003-0080-3     Document Type: Review

References (20)

1. Diabetes Control and Complications Trial (DCCT): the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. DCCT Research Group [no authors listed]. N Engl J Med 1993, 329:977-986.
2. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: a meta-analysis. Diabetes Care 2003, 26:1079-1087.
3. Pickup J, Mattock M, Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomized controlled trials. BMJ 2002, 324:705-708.
4. Bode BW, Steed DR, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996, 19:324-327.
5. Kanakis SJ, Watts C, Leichter SB: The business of insulin pumps in diabetes care: clinical and economic considerations. Clin Diabetes 2002, 20:214-220.
6. Saudek CD, Duckworth WC, Giobbie-Hurder A, et al.: Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus, a randomized clinical trial. JAMA 1996, 276:1322-1327.
7. Thompson JS, Duckworth WC, Saudek CD, Giobbie-Hurder A: Surgical experience with implantable insulin pumps. Am J Surg 1998, 176:622-626.
8. Duckworth WC, Saudek CD, Giobbie-Hurder A, et al.: The Veterans Affairs implantable insulin pump study, effect on cardiovascular risk factors. Diabetes Care 1998, 21:1596-1602.
9. Della Casa L, del Rio G, Glaser B, Cerasi E: Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia. Am J Med 1991, 90(suppl 6A):37S-45S.
10. Ilkova H, Glaser B, Tunckale A, et al.: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 1997, 20:1353-1356.
11. Lormeau B, Aurousseau MH, Valensi P, et al.: Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients. Metabolism 1997, 46:1074-1079.
12. Edelman SV: Pumps and type 2 diabetes. Diabetes Forecast 2002. http://www.diabetes.org/main/community/forecast/june_2002_pumps.jsp.
13. Rosenn B, Miodovnik M, Combs A, et al.: Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994, 84:515-520.
14. Combs CA, Gundeson E, Kitzmiller JL, et al.: Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992, 15:1251-1257.
15. Kuhl C, Andersen GE, Hertel J, Molsted-Pederson L: Metabolic events in the infants of diabetic mothers during the first 24 hours after birth. Acta Pediatr Scand 1982, 71:19-25.
16. Simmons D, Thompson CF, Conroy C, Scott DJ: Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001, 24:2078-2082.
17. Kobayashi T: Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM-the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 1994, 24(suppl):S95-S99.
18. Rizvi AA, Petry R, Arnold MB, Chakraborty M: Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract 2001, 7:364-369.
19. Segal SA,Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002, 51:724-733.
20. Center for Medicare and Medicaid Services, Department of Health and Human Services: Medicare will cover pumps for Medicare beneficiaries. http://cms.hhs.gov/media/press/release.asp?Counter=144. Accessed April 2003.